Organization |
Field Name |
ID |
Required |
---|---|---|---|
KCR |
Grade Post Therapy Clin (yc) |
30141 |
yes |
SEER |
Grade Post Therapy Clin (yc) |
1068 |
yes |
Note 1 Leave Grade Post Therapy Clin (yc) blank when
- No neoadjuvant therapy
- Clinical or pathological case only
- Neoadjuvant therapy completed, no microscopic exam is done prior to surgery/resection of primary tumor
- There is only one grade available and it cannot be determined if it is clinical, pathological, post therapy clinical or post therapy pathological
Note 2 Assign the highest grade from the microscopically sampled specimen of the primary site following neoadjuvant therapy or primary systemic/radiation therapy.
Note 3 If there are multiple tumors with different grades abstracted as one primary, code the highest grade.
Note 4 Priority order for codes
- Invasive cancers codes 1-3 take priority over A-D.
- In situ cancers codes L, M, H take priority over A-D
Note 5 Scarff-Bloom-Richardson (SBR) score is used for grade. SBR is also referred to as Bloom-Richardson, Nottingham, Nottingham modification of Bloom-Richardson score, Nottingham modification, Nottingham-Tenovus grade, or Nottingham score.
Note 6 All invasive breast carcinomas should be assigned a histologic grade. The Nottingham combined histologic grade (Nottingham modification of the SBR grading system) is recommended. The grade for a tumor is determined by assessing morphologic features (tubule formation, nuclear pleomorphism, and mitotic count), assigning a value from 1 (favorable) to 3 (unfavorable) for each feature, and totaling the scores for all three categories. A combined score of 3–5 points is designated as grade 1; a combined score of 6–7 points is grade 2; a combined score of 8–9 points is grade 3.
- Do not calculate the score unless all three components are available
Note 7 Code 9 (unknown) when
- Microscopic exam is done after neoadjuvant therapy and grade from the primary site is not documented
- Microscopic exam is done after neoadjuvant therapy and there is no residual cancer
- Grade checked “not applicable” on CAP Protocol (if available) and no other grade information is available
Note 8 If you are assigning an AJCC 8th edition stage group
- Grade is required to assign stage group
- Codes A-D are treated as an unknown grade when assigning AJCC stage group
- An unknown grade may result in an unknown stage group
Code |
Description |
---|---|
1 |
G1: Low combined histologic grade (favorable), SBR score of 3-5 points |
2 |
G2: Intermediate combined histologic grade (moderately favorable); SBR score of 6-7 points |
3 |
G3: High combined histologic grade (unfavorable); SBR score of 8-9 points |
L |
Nuclear Grade I (Low) (in situ only) |
M |
Nuclear Grade II (interMediate) (in situ only) |
H |
Nuclear Grade III (High) (in situ only) |
A |
Well differentiated |
B |
Moderately differentiated |
C |
Poorly differentiated |
D |
Undifferentiated, anaplastic |
9 |
Grade cannot be assessed (GX); Unknown |
<BLANK> |
See Note 1 |